Clinical response to tepotinib according to circulating tumor (ct)DNA biomarkers in patients with advanced/metastatic NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx) Meeting Abstract
| Authors: | Le, X.; Paz-Ares, L. G.; Van Meerbeeck, J.; Viteri, S.; Cabrera-Galvez, C.; Baz, D. V.; Kim, Y. C.; Kang, J. H.; Stroh, C.; Juraeva, D.; Bruns, R.; Otto, G.; Johne, A.; Paik, P. K. |
| Abstract Title: | Clinical response to tepotinib according to circulating tumor (ct)DNA biomarkers in patients with advanced/metastatic NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx) |
| Meeting Title: | 2022 North America Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Sep 23-25 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-03-01 |
| Start Page: | e3 |
| End Page: | e4 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.09.124 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: OA01.08 -- Accession Number: 161552987 -- Entry Date: In Process -- Revision Date: 20230131 -- Publication Type: Article -- Supplement Title: Mar2023:Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl |
